These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8784612)
1. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. Berrouane YF; Hollis RJ; Pfaller MA J Clin Microbiol; 1996 Jul; 34(7):1856-8. PubMed ID: 8784612 [TBL] [Abstract][Full Text] [Related]
2. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Pfaller MA; Messer SA; Hollis RJ Diagn Microbiol Infect Dis; 1994 Nov; 20(3):127-33. PubMed ID: 7874879 [TBL] [Abstract][Full Text] [Related]
3. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Pfaller MA; Messer SA; Hollis RJ Diagn Microbiol Infect Dis; 1995 Jan; 21(1):9-14. PubMed ID: 7789100 [TBL] [Abstract][Full Text] [Related]
4. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Pfaller MA; Messer SA; Houston A; Rangel-Frausto MS; Wiblin T; Blumberg HM; Edwards JE; Jarvis W; Martin MA; Neu HC; Saiman L; Patterson JE; Dibb JC; Roldan CM; Rinaldi MG; Wenzel RP Diagn Microbiol Infect Dis; 1998 May; 31(1):289-96. PubMed ID: 9597389 [TBL] [Abstract][Full Text] [Related]
5. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis. Zhang J; Hollis RJ; Pfaller MA Diagn Microbiol Infect Dis; 1997 Mar; 27(3):63-7. PubMed ID: 9147006 [TBL] [Abstract][Full Text] [Related]
6. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Marco F; Pfaller MA; Messer S; Jones RN Antimicrob Agents Chemother; 1998 Jan; 42(1):161-3. PubMed ID: 9449278 [TBL] [Abstract][Full Text] [Related]
7. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571 [TBL] [Abstract][Full Text] [Related]
8. Molecular typing for investigating an outbreak of Candida krusei. Noskin GA; Lee J; Hacek DM; Postelnick M; Reisberg BE; Stosor V; Weitzman SA; Peterson LR Diagn Microbiol Infect Dis; 1996; 26(3-4):117-23. PubMed ID: 9078446 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178 [TBL] [Abstract][Full Text] [Related]
11. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
13. Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions. Pfaller MA; Rhine-Chalberg J; Barry AL; Rex JH Clin Infect Dis; 1995 Dec; 21(6):1507-9. PubMed ID: 8749647 [TBL] [Abstract][Full Text] [Related]
14. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. Warnock DW; Johnson EM; Rogers TR J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472 [TBL] [Abstract][Full Text] [Related]
15. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). Swinne D; Watelle M; Van der Flaes M; Nolard N Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180 [TBL] [Abstract][Full Text] [Related]
16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
17. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K; Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267 [TBL] [Abstract][Full Text] [Related]
18. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780 [TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
20. Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013. Zhang L; Zhou S; Pan A; Li J; Liu B Int J Infect Dis; 2015 Apr; 33():1-4. PubMed ID: 25541294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]